Hirofumi Ohashi

Hirofumi Ohashi

Auto-generated profile, based on publicly available information

Hirofumi Ohashi

Division of Medical Genetics, Saitama Children’s Medical Center, Saitama-shi, Japan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2022 in Clinical Genetics
Verified
Journal Article
Closed access
TIToshiyuki Itai
Toshiyuki Itai
ZWZheng Wang
Zheng Wang
GNGen Nishimura
Gen Nishimura
HOHirofumi Ohashi
Hirofumi Ohashi
LGLong Guo
Long Guo
SIShiro Ikegawa
Shiro Ikegawa

17 January 2020 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
KSKenji Shimizu
Kenji Shimizu
DODaiju Oba
Daiju Oba
RNRyusuke Nambu
Ryusuke Nambu
MTManabu Tanaka
Manabu Tanaka
EOEiji Oguma
Eiji Oguma
HOHirofumi Ohashi
Hirofumi Ohashi
Background: Deafness, dystonia, and cerebral hypomyelination (DDCH) is an X‐linked disorder due to hemizygous mutations of BCAP31.Methods: We report an 8‐year‐old boy with DDCH who possibly accompanied mitochondrial dysfunction. Clinical evaluation, respiratory chain enzyme assay, and whole exome sequencing analysis were performed.Results: Mitochondrial dysfunction was suspected by respiratory chain enzyme assay on his cultured skin fibroblasts which showed significantly decreased complex I enzyme activity. Whole exome sequencing analysis revealed a recurrent BCAP31 mutation (c.97C>T:p.Gln33*) which confirmed the diagnosis of DDCH for the patient.Conclusion: We speculate that mitochondrial dysfunction may be a feature in patients with DDCH.

9 October 2024 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
HTHirokazu Takeuchi
Hirokazu Takeuchi
KKKenjiro Kikuchi
Kenjiro Kikuchi
RTRikako Takeda
Rikako Takeda
YHYuko Hirata
Yuko Hirata
RMRyuki Matsuura
Ryuki Matsuura
SHShin-Ichiro Hamano
Shin-Ichiro Hamano

8 September 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MKMikiko Kaneko
Mikiko Kaneko
DODaiju Oba
Daiju Oba
HOHirofumi Ohashi
Hirofumi Ohashi
Many parents face the dilemma of when, how, and what to disclose to their children regarding their genetic conditions. The purpose of this study was to learn about the experiences of parents regarding disclosing information to their children with genetic conditions. A questionnaire was sent to 378 parents of children and adolescents with the following genetic syndromes: 22q11.2 deletion syndrome, Beckwith–Wiedemann syndrome, Noonan syndrome, Russell–Silver syndrome, Kabuki syndrome, Williams syndrome, Prader–Willi syndrome, and Sotos syndrome. Findings were analyzed using descriptive statistics for multiple-choice questions. Of the parents surveyed, 158 (41.8%) responded to the questionnaires. The average age of children with genetic syndromes was 12 years. Sixty-seven parents had disclosed relevant information to their children, whereas 91 had not. Among them (who had disclosed information), out of 53 respondents who answered that their affected child had siblings, 50 had disclosed the genetic condition of the affected child to the siblings as well. Sixty-eight out of 91 respondents who had not told information to affected child were planning to disclose the information in the future. Many respondents who had disclosed information did not regret this. They felt good talking about genetic conditions, and had talked about genetic conditions with the affected children following disclosure. This study contributed to our understanding of the attitudes of parents towards disclosing information to children with genetic syndromes.

17 November 2021 in Research Square
Verified
Preprint
Open access
PDF file
MKMikiko Kaneko
Mikiko Kaneko
DODaijyu Oba
Daijyu Oba
HOHirofumi Ohashi
Hirofumi Ohashi
Many parents face the dilemma of when, how, and what to disclose to their children regarding their genetic conditions. The purpose of this study was to learn about the experiences of parents regarding disclosing information to their children with genetic conditions.Methods: A questionnaire was sent to 378 parents of children and adolescents with the following genetic conditions: 22q11.2 deletion syndrome, Beckwith-Wiedemann syndrome, Noonan syndrome, Russell-Silver syndrome, Kabuki syndrome, Williams syndrome, Prader-Willi syndrome, and Sotos syndrome. Findings were analyzed using descriptive statistics for multiple-choice questions and thematic analysis for open-ended questions.Results: Of the parents surveyed, 158 (41.8 %) responded to the questionnaires. The average age of children with genetic conditions was 12 years. Sixty-seven parents had disclosed relevant information to their children, whereas 91 had not. Sixty-eight out of 91 respondents were planning to disclose information in the future. Many respondents who had disclosed information did not regret this. They felt good talking about genetic conditions, and had talked about genetic conditions with the affected children following disclosure.Conclusion: This study contributed to our understanding of the attitudes of parents towards disclosing information to children with genetic conditions.